Core Viewpoint - The company has completed an additional capital injection of 30 million HKD into its wholly-owned subsidiary TGM, bringing TGM's total paid-up capital to 150 million HKD, which is expected to strengthen TGM's capital base and support its business expansion [1][2] Group 1: Capital Injection Details - The total capital injection into TGM has reached 83 million HKD prior to this latest round, with the recent injection of 30 million HKD completed on November 20, 2025 [1] - Following this capital increase, the company's ownership percentage in TGM remains unchanged [1] Group 2: TGM's Performance and Future Prospects - TGM has shown impressive performance with revenues of approximately 44.9 million HKD for the six months ending September 30, 2025, marking a nearly 400% increase compared to the same period last year [1] - The capital enhancement is expected to significantly improve TGM's risk resilience and business capacity, providing a solid foundation for expanding its IPO underwriting and margin financing business [2] - Strengthening the capital base will further enhance TGM's market competitiveness and industry position, creating favorable conditions for exploring emerging business areas [2]
捷利交易宝完成对TGM进一步增资3000万港元